ADIM
CVX icon

Alpha DNA Investment Management’s Chevron CVX Stock Holding History

Alpha DNA Investment Management’s Portfolio CVX Stock Details CVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,716
Closed -$973K – 55
2024
Q4 		$973K Buy
6,716
+152
+2% +$23.3K 0.37% 50
2024
Q3 		$967K Sell
6,564
-7,788
-54% -$1.16M 0.36% 58
2024
Q2 		$2.24M Buy
14,352
+6,504
+83% +$1.04M 0.87% 16
2024
Q1 		$1.24M Sell
7,848
-16,017
-67% -$2.42M 0.46% 40
2023
Q4 		$3.56M Buy
23,865
+16,570
+227% +$2.51M 1.39% 7
2023
Q3 		$1.23M Buy
7,295
+680
+10% +$110K 0.5% 37
2023
Q2 		$1.04M Sell
6,615
-5,018
-43% -$804K 0.35% 67
2023
Q1 		$1.9M Buy
11,633
+1,133
+11% +$190K 0.56% 21
2022
Q4 		$1.88M Sell
10,500
-6,100
-37% -$1.06M 0.67% 17
2022
Q3 		$2.38M Buy
16,600
+8,197
+98% +$1.25M 1.98% 4
2022
Q2 		$1.22M Sell
8,403
-722
-8% -$119K 1.04% 9
2022
Q1 		$1.49M Buy
+9,125
New +$1.31M 1.04% 5
2021
Q2 		– Sell
-431
Closed -$45K – 220
2021
Q1 		$45K Buy
431
+58
+16% +$5.66K 0.05% 187
2020
Q4 		$31K Buy
+373
New +$30.2K 0.03% 222

Other funds holding CVX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Alpha DNA Investment Management's CVX Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Chevron (CVX) in Q1 2025, closing a stake of 6,716 shares — an estimated $973K sold.

Alpha DNA Investment Management first reported a position in CVX in Q4 2020 and held it in 14 quarters. The position peaked at $3.56M in Q4 2023. 3,815 funds tracked by Wall St. Rank hold CVX as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Chevron position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 6,716 Chevron shares in Q1 2025, an estimated $973K.
  • Alpha DNA Investment Management first reported a position in Chevron in Q4 2020 and held it in 14 quarters.
  • Alpha DNA Investment Management's Chevron position peaked at $3.56M in Q4 2023.
  • 3,815 funds tracked by Wall St. Rank held Chevron as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.